shutterstock_1857404794_michael_vi
Michael Vi / Shutterstock.com
2 February 2021GeneticsAlex Baldwin

Illumina wins PTAB appeal over Columbia DNA patents

Biotech company Illumina has won a dispute with Columbia University, after the Court of Appeals for the Federal Circuit backed an earlier ruling that the university’s DNA-sequencing patents were invalid.

Already registered?

Login to your account

To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.

Two Weeks Free Trial

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk


More on this story

Big Pharma
4 October 2019   A US subsidiary of Chinese genome sequencing company BGI has filed a patent infringement counterclaim against Illumina.
Americas
1 February 2016   The US Court of Appeals for the Federal Circuit has knocked out two patents belonging to biotechnology company Illumina following a challenge by Intelligent Bio-Systems.

More on this story

Big Pharma
4 October 2019   A US subsidiary of Chinese genome sequencing company BGI has filed a patent infringement counterclaim against Illumina.
Americas
1 February 2016   The US Court of Appeals for the Federal Circuit has knocked out two patents belonging to biotechnology company Illumina following a challenge by Intelligent Bio-Systems.

More on this story

Big Pharma
4 October 2019   A US subsidiary of Chinese genome sequencing company BGI has filed a patent infringement counterclaim against Illumina.
Americas
1 February 2016   The US Court of Appeals for the Federal Circuit has knocked out two patents belonging to biotechnology company Illumina following a challenge by Intelligent Bio-Systems.